BDMD · Baird Medical Investment Holdings Ltd
$1.04
-0.01 (-0.48%)
At close · Jul 31
Market Cap
$42.62M
Shares
40.98M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.04
Open$1.01
Day$1.01–1.09
52W$0.76–3.75
Avg vol 30d88K
Short int20K · 0.0% float · 1.0d
Short vol3%
DataDec 2021–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 17.1 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−31%
below
Price vs 50-day avg
−14%
below
RSI (14)
40
neutral
MACD trend
Positive
52-week position
9%
near low
Momentum
relative strength
1-month return
−8%
trailing
6-month return
+15%
trailing
YTD return
−24%
this year
Relative strength
+5%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.05% of float · ▼ -40.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
8 holders — mid 1-yr range
Squeeze score
17
low risk · 0–100
Fundamentals
Revenue growth
−39%
Y/Y
Gross margin
84%
contracting
EPS growth
−272%
Y/Y
Free cash flow
$-1.4M
Balance sheet
$8.5M
net debt
Quant / Vol
risk profile
Volatility
121%
annualized · 1-yr
Max drawdown
−72%
past year
ATR
10.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−31%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
40
Neutral
MACD trend
Positive
Bullish
52-week position
9%
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.05% of float · ▼ -40.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
8 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 9%
52-wk high $4
vs 200-day avg -31%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BDMD
this stock
Baird Medical Investment Holdings Ltd
|
$42.62M | -23.5% | -39.2% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$183.95B | -15.3% | +5.7% | 29.6 | 1.4% |
|
SYK
Stryker Corp
|
$133.42B | -0.7% | +11.2% | 36.1 | 1.8% |
|
MDT
Medtronic plc
|
$109.71B | -10.0% | +8.4% | 23.0 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.73B | -51.8% | +5.5% | 19.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
8
- % held
- 0.8%
- Net QoQ
- -193.1K sh
- Top holder
- HIGHBRIDGE CAPITAL MANAGE…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BDMD | +2.0% | -8.0% | +14.9% | -9.6% | -23.5% |
| SPY | +0.5% | -0.6% | +9.5% | -0.7% | +8.8% |
| vs SPY | +1.5% | -7.4% | +5.5% | -8.9% | -32.3% |